Inverse in silico screening for identification of kinase inhibitor targets.
about
Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cellsBinding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurementsA miRNA-driven inference model to construct potential drug-disease associations for drug repositioningThe interprotein scoring noises in glide docking scores.Virtual target screening: validation using kinase inhibitors.An inverse docking approach for identifying new potential anti-cancer targets.Exploiting drug-disease relationships for computational drug repositioning.idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approachDrug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma.Characterization of anti-leukemia components from Indigo naturalis using comprehensive two-dimensional K562/cell membrane chromatography and in silico target identification.Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applicationsReverse docking: a powerful tool for drug repositioning and drug rescue.Modeling conformational transitions in kinases by molecular dynamics simulations: achievements, difficulties, and open challengesUsing reverse docking for target identification and its applications for drug discovery.Indirubin derivatives inhibit malignant lymphoid cell proliferation.Computational Modeling of Kinase Inhibitor Selectivity.6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.Using reverse docking to identify potential targets for ginsenosides.The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.Rare Diseases: Drug Discovery and Informatics Resource.What is the potential of structure-based target prediction methods?RepurposeVS: A Drug Repurposing-Focused Computational Method for Accurate Drug-Target Signature Predictions.Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds.Docking-based inverse virtual screening: methods, applications, and challenges.Ligand Selectivity between the ADP-Ribosylating Toxins: An Inverse-Docking Study for Multitarget Drug Discovery.
P2860
Q21142682-19CF7590-849D-4361-AAB5-03D5848AAA1CQ28475132-D6E6888E-4446-42A6-A790-0C43781A4EB9Q28652746-3A969BC0-724A-4CAB-8510-0CDCE164D368Q34061894-156C0BDC-34D6-4414-8CF5-3C07A877950BQ34321892-27FB8031-555E-4E14-B284-76FCF46EFB5FQ34744590-932A215B-6365-4556-9EB9-C06C01D0180CQ35109885-2E392127-4E1E-4CF4-853E-AF429C1B48DDQ36088437-19FA4CEE-78E0-4E22-A885-CB5B5DCD79B3Q36340148-F68C33AC-DBDF-491A-A92E-8C7D2A676D6DQ36875177-87DFA178-F82F-4CB4-8BBB-318AA5CDA65CQ36933260-7B5F6614-4F9B-45CD-BEA1-1ECFADAE3433Q38191684-088243DE-94D7-4781-B11C-FF2D9FAFDD7BQ38214683-96D34C0C-0E30-4EA3-98A4-E5F0B55018C0Q38836168-B34CACEA-8E4D-4C56-A0BA-615C0FD0D924Q39783011-4A11ECC9-C7DC-4F67-B305-9A04E531EC53Q40201863-4A8E5981-3EBA-4078-AB8B-2DC2C54B93E1Q41718283-2915EEA2-6160-4D5A-BA85-8CC5C8C2D138Q42279211-573FE508-033D-4644-B15F-F233AD46913CQ43950297-E23EEA91-9EEB-4BAD-B052-7BD9B3289501Q45873887-92820CBC-DCEC-42AF-91D5-E7324EE87C46Q48658624-D73785F4-60E8-4FB3-BD90-837D585DF99EQ50872451-EE9B0758-438F-4040-9A26-7B26358D1754Q55093753-907CD4F5-3C39-4894-BE2A-75D7A57E90D0Q55341853-09092193-8C80-4FBE-BA36-2D63033FCC28Q55691227-7EEFF673-06CB-443C-8372-38A65B4DED1E
P2860
Inverse in silico screening for identification of kinase inhibitor targets.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inverse in silico screening for identification of kinase inhibitor targets.
@en
type
label
Inverse in silico screening for identification of kinase inhibitor targets.
@en
prefLabel
Inverse in silico screening for identification of kinase inhibitor targets.
@en
P2093
P1476
Inverse in silico screening for identification of kinase inhibitor targets
@en
P2093
Angelika M Vollmar
Frank Totzke
Joannis Apostolakis
Laurent Meijer
Michael Kubbutat
Simon Tietze
P304
P356
10.1016/J.CHEMBIOL.2007.10.010
P577
2007-11-01T00:00:00Z